China Shineway Pharmaceutical Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSWYY research report →
Companywww.shineway.com
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products.
- CEO
- Zhenjiang Li
- IPO
- 2012
- Employees
- 3,220
- HQ
- Shijiazhuang, CN
Price Chart
Valuation
- Market Cap
- $36.35M
- P/E
- 5.85
- P/S
- 1.77
- P/B
- 0.69
- EV/EBITDA
- -1.76
- Div Yield
- 7.16%
Profitability
- Gross Margin
- 72.28%
- Op Margin
- 21.75%
- Net Margin
- 30.30%
- ROE
- 11.97%
- ROIC
- 5.93%
Growth & Income
- Revenue
- $3.05B · -19.27%
- Net Income
- $924.07M · 10.00%
- EPS
- $489.40 · 10.23%
- Op Income
- $663.48M
- FCF YoY
- 18.36%
Performance & Tape
- 52W High
- $22.54
- 52W Low
- $19.25
- 50D MA
- $19.25
- 200D MA
- $19.25
- Beta
- 0.83
- Avg Volume
- 0.94
Get TickerSpark's AI analysis on CSWYY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CSWYY Coverage
We haven't published any research on CSWYY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CSWYY Report →